NASDAQ · SIGA
SIGA Technologies Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SIGA: Nov 09, 2026
SIGA Technologies Inc. Common Stock is expected to report earnings on 11/09/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-0.09.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · BNK Invest · The Motley Fool · MarketBeat- RTTNews · Oct 28, 8:30 AM EDTSIGA Wins Canadian Defence Contract Worth Up To $15M For Smallpox Antiviral; Stock Up(RTTNews) – SIGA Technologies, Inc. (SIGA) announced that Public Services and Procurement Canada has awarded the company a contract valued at up to approximately $15 million for oral TPOXX (tecovirimat), an antiviral medication used to treat smallpox, on behalf of the Canadian De
- BNK Invest · Oct 1, 11:50 AM EDTHow To YieldBoost SIGA To 37.4% Using OptionsShareholders of SIGA Technologies Inc (Symbol: SIGA) looking to boost their income beyond the stock's 18% annualized dividend yield can sell the March 2027 covered call at the $4 strike and collect the premium based on the 30 cents bid, which annualizes to an additional 19.4% ra
- The Motley Fool · Aug 13, 9:17 PM EDTSIGA (SIGA) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 7, 8:03 AM EDTSiga Technologies Q2 Earnings Call HighlightsGeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?Siga Technologies (NASDAQ:SIGA) reported second-quarter product-related revenue of $38 million, driven primarily by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to inter
- MarketBeat · May 8, 9:06 PM EDTSiga Technologies Q1 Earnings Call HighlightsGeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?Siga Technologies (NASDAQ:SIGA) reported a first-quarter loss as product deliveries remained minimal, but management said it expects a pickup in the second quarter tied to an international order and additional deliveri
- The Motley Fool · May 7, 5:35 PM EDTSIGA (SIGA) Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Mar 11, 1:19 AM EDTSIGA Q4 And FY25 Revenue Declines(RTTNews) – SIGA Technologies, Inc. (SIGA), a commercial-stage pharmaceutical company, reported a decline in revenue for the fourth quarter and the full year ended December 31, 2025.
- Validea · Oct 6, 11:00 AM EDTValidea's Top Health Care Stocks Based On Joel Greenblatt – 10/6/2025The following are the top rated Health Care stocks according to Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.SIGA TECHNOLOGIES INC (SIGA) is a small
- Validea · Sep 4, 5:34 AM EDTValidea Motley Fool Strategy Daily Upgrade Report – 9/4/2025The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.SIGA TECHNOLOGIES INC (SIGA) is a small-cap value
- BNK Invest · Aug 29, 9:30 AM EDTHealthcare Is Sickly, But These Yields up to 7% May Still Have a PulseHealthcare stocks haven't moved since the April lows. As contrarian investors, this neglect piques our interest.
- Validea · Aug 12, 6:17 AM EDTValidea Motley Fool Strategy Daily Upgrade Report – 8/12/2025The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.REX AMERICAN RESOURCES CORP (REX) is a small-cap g
- The Motley Fool · Aug 6, 10:18 AM EDTSIGA (SIGA) Q2 Revenue Soars 272%GAAP revenue reached $81.1 million in Q2 2025, driven by large U.S. government TPOXX deliveries.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for SIGA Technologies Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.